Statin trials
This article was originally published in The Tan Sheet
Executive Summary
"The opportunity to conduct placebo-controlled statin trials may soon disappear" due to trends toward broader statin use in the U.S. and UK populations, Ernest Hawk, MD, and Jaye Viner, MD, National Cancer Institute, state in a recent editorial in the New England Journal of Medicine. "Current treatment guidelines specify the use of statin therapy in patients at high risk for cardiovascular disease, but placebo-controlled testing against a variety of end points could still be ethically conducted in populations at average risk," the authors maintain. The editorial accompanies a study by Jenny Poynter, University of Michigan, et al., linking statins including Zocor (simvastatin) and Pravachol (pravastatin) to a significantly reduced relative risk of colorectal cancer...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.